Tumor necrosis factor-alpha (TNF-α) inhibitors have proven to be effective drugs for various rheumatologic diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel diseases. Here, TNF is linked to inflammatory bowel disease.